Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bonmassar

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Interrelationship between chemotherapy and immunotherapy in the treatment of disseminated diseaseA Goldin, A Nicolin, E Bonmassar
Pharmacological Research|September 1, 1992
Biological basis for immunopharmacology in the control of early infection with human retrovirusesC D'Onofrio, M Guerriero, E Bonmassar
Transplantation|October 1, 1971
Differential reactivity of mice to alloantigens associated with the D and K end of H-2: preliminary studies with bone marrow and lymphoma graftsE Bonmassar, A Goldin, G Cudkowicz
International Journal of Immunopharmacology|January 1, 1984
Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cellsF Campanile, A M Iorio, E Bonmassar
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemiaM P Fuggetta, C D'Onofrio, E Bonmassar
Progress in Clinical and Biological Research|January 1, 1983
Antigenic changes related to drug actionM C Fioretti, L Romani, E Bonmassar
Transplantation|September 1, 1979
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivoL Romani, M C Fioretti, E Bonmassar
Journal of Immunopharmacology|January 1, 1981
Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitroG Migliorati, L Frati, A Barzi, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1995
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL)L Tentori, C Leonetti, F Lozupone, et al.
International Journal of Immunopharmacology|November 1, 1996
Functional antagonism between IL-2 and PGA1 or PGJ2 in the control of proliferation of human cord blood-derived mononuclear cellsO Franzese, E Bonmassar, A Marcucci, et al.
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Interrelationship between chemotherapy and immunotherapy in the treatment of disseminated diseaseA Goldin, A Nicolin, E Bonmassar
Pharmacological Research|September 1, 1992
Biological basis for immunopharmacology in the control of early infection with human retrovirusesC D'Onofrio, M Guerriero, E Bonmassar
Transplantation|October 1, 1971
Differential reactivity of mice to alloantigens associated with the D and K end of H-2: preliminary studies with bone marrow and lymphoma graftsE Bonmassar, A Goldin, G Cudkowicz
International Journal of Immunopharmacology|January 1, 1984
Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cellsF Campanile, A M Iorio, E Bonmassar
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemiaM P Fuggetta, C D'Onofrio, E Bonmassar
Progress in Clinical and Biological Research|January 1, 1983
Antigenic changes related to drug actionM C Fioretti, L Romani, E Bonmassar
Transplantation|September 1, 1979
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivoL Romani, M C Fioretti, E Bonmassar
Journal of Immunopharmacology|January 1, 1981
Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitroG Migliorati, L Frati, A Barzi, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1995
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL)L Tentori, C Leonetti, F Lozupone, et al.
International Journal of Immunopharmacology|November 1, 1996
Functional antagonism between IL-2 and PGA1 or PGJ2 in the control of proliferation of human cord blood-derived mononuclear cellsO Franzese, E Bonmassar, A Marcucci, et al.
Pageof 19